Literature DB >> 23053639

Efficacy of 'radioguided occult lesion localisation' (ROLL) versus 'wire-guided localisation' (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial.

E L Postma1, H M Verkooijen, S van Esser, M G Hobbelink, G P van der Schelling, R Koelemij, A J Witkamp, C Contant, P J van Diest, S M Willems, I H M Borel Rinkes, M A A J van den Bosch, W P Mali, R van Hillegersberg.   

Abstract

For the management of non-palpable breast cancer, accurate pre-operative localisation is essential to achieve complete resection with optimal cosmetic results. Radioguided occult lesions localisation (ROLL) uses the radiotracer, injected intra-tumourally for sentinel lymph node identification to guide surgical excision of the primary tumour. In a multicentre randomised controlled trial, we determined if ROLL is superior to the standard of care (i.e. wire-guided localisation, WGL) for preoperative tumour localisation. Women (>18 years.) with histologically proven non-palpable breast cancer and eligible for breast conserving treatment with sentinel node procedure were randomised to ROLL or WGL. Patients allocated to ROLL received an intra-tumoural dose of 120 Mbq technetium-99 m nanocolloid. The tumour was surgically removed, guided by gamma probe detection. In the WGL group, ultrasound- or mammography-guided insertion of a hooked wire provided surgical guidance for excision of the primary tumour. Primary outcome measures were the proportion of complete tumour excisions (i.e. with negative margins), the proportion of patients requiring re-excision and the volume of tissue removed. Data were analysed according to intention-to-treat principle. This study is registered at ClinincalTrials.gov, number NCT00539474. In total, 314 patients with 316 invasive breast cancers were enrolled. Complete tumour removal with negative margins was achieved in 140/162 (86 %) patients in the ROLL group versus 134/152 (88 %) patients in the WGL group (P = 0.644). Re-excision was required in 19/162 (12 %) patients in the ROLL group versus 15/152 (10 %) (P = 0.587) in the WGL group. Specimen volumes in the ROLL arm were significantly larger than those in the WGL arm (71 vs. 64 cm(3), P = 0.017). No significant differences were seen in the duration and difficulty of the radiological and surgical procedures, the success rate of the sentinel node procedure, and cosmetic outcomes. In this first multicentre randomised controlled comparison of ROLL versus WGL in patients with histologically proven breast cancer, ROLL is comparable to WGL in terms of complete tumour excision and re-excision rates. ROLL, however, leads to excision of larger tissue volumes. Therefore, ROLL cannot replace WGL as the standard of care.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053639     DOI: 10.1007/s10549-012-2225-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  11 in total

1.  iROLL: does 3-D radioguided occult lesion localization improve surgical management in early-stage breast cancer?

Authors:  Christina Bluemel; Andreas Cramer; Christoph Grossmann; Georg W Kajdi; Uwe Malzahn; Nora Lamp; Heinz-Jakob Langen; Jan Schmid; Andreas K Buck; Hanns-Jörg Grimminger; Ken Herrmann
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-09       Impact factor: 9.236

2.  Incidence and risk factors of the intraoperative localization failure of nonpalpable breast lesions by radio-guided occult lesion localization: a retrospective analysis of 579 cases: reply.

Authors:  Emily L Postma; Helena M Verkooijen; Maurice A A J van den Bosch; Richard van Hillegersberg
Journal:  World J Surg       Date:  2013-02       Impact factor: 3.352

Review 3.  Current status of ultrasound-guided surgery in the treatment of breast cancer.

Authors:  José H Volders; Max H Haloua; Nicole Ma Krekel; Sybren Meijer; Petrousjka M van den Tol
Journal:  World J Clin Oncol       Date:  2016-02-10

4.  Combined LOCalizer™ and Intraoperative Ultrasound Localization: First Experience in Localization of Non-palpable Breast Cancer.

Authors:  Simona Parisi; Roberto Ruggiero; Giorgia Gualtieri; Mariachiara Lanza Volpe; Serena Rinaldi; Giusiana Nesta; Lidija Bogdanovich; Francesco Saverio Lucido; Salvatore Tolone; Domenico Parmeggiani; Claudio Gambardella; Ludovico Docimo
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

Review 5.  Use of Diagnostic Imaging Modalities in Modern Screening, Diagnostics and Management of Breast Tumours 1st Central-Eastern European Professional Consensus Statement on Breast Cancer.

Authors:  Gábor Forrai; Eszter Kovács; Éva Ambrózay; Miklós Barta; Katalin Borbély; Zsolt Lengyel; Katalin Ormándi; Zoltán Péntek; Tasnádi Tünde; Éva Sebő
Journal:  Pathol Oncol Res       Date:  2022-06-08       Impact factor: 2.874

6.  Ectopic breast localization wire in the pleural cavity: A case report.

Authors:  Xuelu Li; Dandan Zhu; Man Li; Zuowei Zhao
Journal:  Mol Clin Oncol       Date:  2018-03-26

7.  Radioactive seed localization compared with wire-guided localization of non-palpable breast carcinoma in breast conservation surgery- the first experience in the United Kingdom.

Authors:  Robert Milligan; Andrew Pieri; Adam Critchley; Richard Peace; Tom Lennard; J M O'Donoghue; Rachel Howitt; Stewart Nicholson; Henry Cain; George Petrides; Nidhi Sibal
Journal:  Br J Radiol       Date:  2017-11-16       Impact factor: 3.039

8.  Predictive Factors for Positive Margin and the Surgical Learning Curve in Non-Palpable Breast Cancer After Wire-Guided Localization - Prospective Study of 214 Consecutive Patients.

Authors:  Dezső Tóth; Zsolt Varga; Éva Sebő; Miklós Török; Ilona Kovács
Journal:  Pathol Oncol Res       Date:  2015-11-02       Impact factor: 3.201

Review 9.  Localization techniques for guided surgical excision of non-palpable breast lesions.

Authors:  Benjamin K Y Chan; Jill A Wiseberg-Firtell; Ramesh H S Jois; Katrin Jensen; Riccardo A Audisio
Journal:  Cochrane Database Syst Rev       Date:  2015-12-31

10.  Rolling out radioguided occult lesion localisation for breast tumours.

Authors:  David K V Chung
Journal:  J Med Radiat Sci       Date:  2015-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.